Trial Details
COMPLETEDBasic Information
| Clinical ID | c1572 |
|---|---|
| Identifier | NCT02678052 |
| Trial Title | OTIS Vedolizumab Pregnancy Exposure Registry |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative|Crohn's Disease |
| Interventions | DRUG: Vedolizumab|BIOLOGICAL: Other Biological Agent |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | San Diego |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2015-12-01 |
|---|---|
| Primary Completion Date | 2022-07-15 |
| Completion Date | 2022-07-31 |